Sign Up for Our Newsletter
Contact Donate

Mantle Cell Lymphoma

Program Status


Open –  We are accepting applications for new and renewal patients. If your application for assistance is approved you can begin receiving funding immediately.

Maximum Award Level

$ 10,000 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

 Patient must have Medicare insurance coverage and must cover the medication for which patient seeks assistance.
The medication must treat the disease directly.
Patient must reside and receive treatment in the United States.
Patient’s income must fall below 500% of the Federal Poverty Level.

Get Help With Your Treatment

Apply Online (Click Here) or call 1-866-316-PANF (7263)

Information About the Disease

Mantle cell lymphoma (MCL) results from a malignant transformation of a B lymphocyte in the outer edge of a lymph node follicle (the mantle zone). The transformed B lymphocyte grows in an uncontrolled way and the accumulated lymphoma cells form tumors in lymph nodes, which leads to their enlargement. The MCL cells can enter the lymphatic channels and the blood, and can spread to other lymph nodes or tissues, such as the marrow, liver and gastrointestinal tract.

There are about 66,360 new cases of NHL in the United States each year. MCL patients represent about 6 percent of all new cases of NHL per year. MCL occurs more frequently in older adults—the average age-range at diagnosis is the mid-60s; it is more often diagnosed in males than in females; and white males and females are at a higher risk than black males and females for an MCL diagnosis.

For more information visit the Leukemia & Lymphoma Society website.